T1	Participants 74 86	osteoporosis
T2	Participants 506 600	women aged 50 years to 86 years starting treatment with raloxifene according to daily practice
T3	Participants 659 664	women
T4	Participants 1661 1751	After receiving an educational leaflet, young post-menopausal women suffering osteoporosis
